Interest in generic drugs has been constantly expanding, especially after the state's decision to provide incentives to boost the consumption of generic drugs, in order to keep public pharmaceutical expenditure at low levels.
Several pharmaceutical companies, mostly manufacturers, operate in the Greek market of generic drugs.
According to sector insiders, domestically produced generic drugs account for 45% -50% of the total domestically produced medicines.
Generic penetration in the total domestic (hospital and outpatient) drug market amounted to 18% (in value) and 23% (in volume) in 2017.